Cargando…

The ZOTECT study: Effect of zoledronic acid on bone metabolism in patients with bone metastases from prostate or breast cancer

PURPOSE: The ZOTECT study assesses the effect of zoledronic acid (ZOL) on bone-marker levels and potential correlations with disease outcomes in bisphosphonate-naive patients. METHODS: This prospective, single-arm, open-label study in bisphosphonate-naive (≥6 months) patients with bone metastases fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hadji, Peyman, Ziller, May, Maurer, Tobias, Autenrieth, Michael, Muth, Mathias, Ruebel, Amelie, May, Christoph, Birkholz, Katrin, Diebel, Erhardt, Gleissner, Jochen, Rothe, Peter, Gschwend, Juergen E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723349/ https://www.ncbi.nlm.nih.gov/pubmed/26909262 http://dx.doi.org/10.1016/j.jbo.2012.07.002

Ejemplares similares

The impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasis
por: Hadji, P., et al.
Publicado: (2012)

Prevention of bone metastases and management of bone health in early breast cancer
por: Gnant, Michael, et al.
Publicado: (2010)

The effect of zoledronate during bone healing
por: Matos, Marcos Almeida, et al.
Publicado: (2010)

Bone Oncology—An emerging multi-disciplinary specialty
por: Coleman, Robert, et al.
Publicado: (2012)

Zoledronic acid in the management of metastatic bone disease
por: Polascik, Thomas J, et al.
Publicado: (2008)

Cryoablation combined with zoledronic acid in comparison with cryoablation and zoledronic acid alone in the treatment of painful bone metastases
por: LI, FENQIANG, et al.
Publicado: (2014)

Zoledronic acid sequential to teriparatide may promote greater inhibition of bone resorption than zoledronic acid alone
por: Giveon, Sharon, et al.
Publicado: (2023)

Bone structure and remodelling in stroke patients: Early effects of zoledronate()
por: Poole, Kenneth E.S., et al.
Publicado: (2009)

Controlled Delivery of Zoledronate Improved Bone Formation Locally In Vivo
por: Gou, Wenlong, et al.
Publicado: (2014)

Bone-seeking nanoplatform co-delivering cisplatin and zoledronate for synergistic therapy of breast cancer bone metastasis and bone resorption
por: Huang, Yanjuan, et al.
Publicado: (2020)

Protection of bone in premenopausal women with breast cancer: focus on zoledronic acid
por: Aft, Rebecca
Publicado: (2012)

Low-dose zoledronate for the treatment of bone metastasis secondary to prostate cancer
por: Akoury, Elie, et al.
Publicado: (2019)

Zoledronic acid for prevention of bone loss in patients receiving bariatric surgery
por: Liu, Yi, et al.
Publicado: (2021)

Insufficient Mitigation of Bone Loss by Zoledronic Acid after Treatment with Denosumab
por: Park, Jung-Wee
Publicado: (2021)

Effect of Acetazolamide and Zoledronate on Simulated High Altitude-Induced Bone Loss
por: Brent, Mikkel Bo, et al.
Publicado: (2022)

Zoledronate combined metal-organic frameworks for bone-targeting and drugs deliveries
por: Pan, Yixiao, et al.
Publicado: (2022)

Zoledronic Acid Implant Coating Results in Local Medullary Bone Growth
por: Quarterman, Juliana C., et al.
Publicado: (2022)

Dietary nitrate improves jaw bone remodelling in zoledronate‐treated mice
por: Pan, Wen, et al.
Publicado: (2023)

Local treatment of a bone graft by soaking in zoledronic acid inhibits bone resorption and bone formation. A bone chamber study in rats
por: Belfrage, Ola, et al.
Publicado: (2012)

Differential effect of zoledronic acid on normal trabecular and cortical bone density in oncologic patients with bone metastases
por: Quattrocchi, Carlo C., et al.
Publicado: (2012)

Zoledronic Acid Ameliorates the Bone Turnover Activity and Periprosthetic Bone Preservation in Cementless Total Hip Arthroplasty
por: Hsu, Allen Herng Shouh, et al.
Publicado: (2022)

Bone Morphogenetic Protein 2 Promotes Bone Formation in Bone Defects in Which Bone Remodeling Is Suppressed by Long-Term and High-Dose Zoledronic Acid
por: Moon, Young Jae, et al.
Publicado: (2023)

Effect of Teriparatide on Subsequent Fracture and Bone Mineral Density in 47 Women with Pregnancy- and Lactation-associated Osteoporosis and Vertebral Fractures
por: Hadji, Peyman, et al.
Publicado: (2022)

Zoledronic acid and atorvastatin inhibit αvβ3-mediated adhesion of breast cancer cells
por: Wilke, Maria, et al.
Publicado: (2014)

Effects of local delivery of BMP2, zoledronate and their combination on bone microarchitecture, biomechanics and bone turnover in osteoporotic rabbits
por: Jing, Da, et al.
Publicado: (2016)

Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women
por: Lambrinoudaki, Irene, et al.
Publicado: (2008)

Zoledronic acid: clinical utility and patient considerations in osteoporosis and low bone mass
por: Hamdy, Ronald C
Publicado: (2010)

Guided bone regeneration with local zoledronic acid and titanium barrier: An experimental study
por: Dundar, Serkan, et al.
Publicado: (2016)

Local treatment of cancellous bone grafts with BMP-7 and zoledronate increases both the bone formation rate and bone density: A bone chamber study in rats
por: Belfrage, Ola, et al.
Publicado: (2011)

Topical co‐administration of zoledronate with recombinant human bone morphogenetic protein-2 can induce and maintain bone formation in the bone marrow environment
por: Ueyama, Hideki, et al.
Publicado: (2021)

Assessment of the Effects of Zoledronic Acid Therapy on Bone Metabolic Indicators in Hormone-Resistant Prostate Cancer Patients with Bone Metastatasis
por: Demirtas, Abdullah, et al.
Publicado: (2011)

A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis
por: Le Goff, Benoit, et al.
Publicado: (2009)

A Biphasic Calcium Sulphate/Hydroxyapatite Carrier Containing Bone Morphogenic Protein-2 and Zoledronic Acid Generates Bone
por: Raina, Deepak Bushan, et al.
Publicado: (2016)

Negative effect of zoledronic acid on tendon-to-bone healing: In vivo study of biomechanics and bone remodeling in a rat model
por: Hjorthaug, Geir Aasmund, et al.
Publicado: (2018)

Comparison of Denosumab and Zoledronic Acid in Postmenopausal Women With Osteoporosis: Bone Mineral Density (BMD) and Trabecular Bone Score (TBS)
por: Kang, Taewook, et al.
Publicado: (2022)

Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment - the COMPAS study
por: Ziller, Volker, et al.
Publicado: (2013)

Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment
por: Brubaker, Kristen D, et al.
Publicado: (2006)

Zoledronic acid protects from local and systemic bone loss in TNF-mediated arthritis
por: Zwerina, J, et al.
Publicado: (2004)

Data in support of the bone analysis of NOD–SCID mice treated with zoledronic acid and prednisolone
por: Hori, Naoko, et al.
Publicado: (2016)

Subgroup Variations in Bone Mineral Density Response to Zoledronic Acid After Hip Fracture
por: Magaziner, Jay S, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_coipd8mfrtj4s457qv6bdh2ks3